NAD+ Therapy for California Clinics: Supply & Compliance Guide
California medical practices offering NAD+ subcutaneous injections need a reliable cGMP supply partner. Here is what California providers need to know about ordering NAD+ compliantly.
California's longevity medicine and wellness clinic industry is one of the most sophisticated in the world. From Beverly Hills and Santa Monica's world-class medical spas to San Francisco's functional medicine community, San Diego's sports medicine and biohacking market, and Silicon Valley's executive health practices, California providers are at the forefront of NAD+ therapy adoption.
If you operate a licensed medical practice in California and you're looking to add or expand NAD+ subcutaneous injections, this guide covers supply standards, California's specific regulatory requirements, and how to get your clinic set up with a compliant supply partner.
The California NAD+ Market
California's clinic landscape is the most diverse in the country, and NAD+ is being offered across a wide range of clinical contexts.
Los Angeles and Beverly Hills β LA's medical spa and longevity clinic industry is among the most active NAD+ markets in the world. Beverly Hills and Santa Monica practices typically offer NAD+ as part of comprehensive longevity programs combining GLP-1s, peptides, hormone optimization, and aesthetic treatments.
San Francisco Bay Area β The Bay Area's functional medicine and biohacking community has been an early adopter of NAD+ therapy. Silicon Valley executive health practices offer NAD+ for cognitive performance, energy optimization, and stress resilience.
San Diego β San Diego's sports medicine, military health, and active lifestyle demographics make NAD+ a natural fit for performance optimization and recovery protocols.
Sacramento and Central Valley β Growing markets with demand from primary care and integrative health practices adding NAD+ to their service offerings.
California Regulatory Considerations for NAD+ Therapy
California's regulatory environment is more complex than most states. NAD+ providers should be aware of several specific requirements.
California State Board of Pharmacy Compliance β Out-of-state 503B facilities shipping compounded NAD+ to California must hold a California non-resident pharmacy license in addition to their FDA registration. MedClinic Partners works exclusively with suppliers that hold the appropriate California licensure.
Prescribing Requirements β NAD+ subcutaneous injections require a valid prescription from a licensed California provider. California requires a valid patient-provider relationship and thorough patient documentation for compounded medication prescribing.
Storage Requirements β Compounded NAD+ injectables require refrigeration at 2β8Β°C. California practices must maintain compliant medication storage logs.
Medical Board of California Standards β California providers should ensure their NAD+ protocols align with Medical Board of California standards for compounded medication prescribing and documentation.
NAD+ Supply Standards for California Clinics
USA cGMP Manufacturing β NAD+ for injection must be manufactured in a cGMP-compliant, FDA-registered USA facility. MedClinic Partners supplies NAD+ exclusively from USA-based cGMP manufacturers.
USP <797> Sterile Compounding β Injectable NAD+ must be compounded under USP <797> sterile conditions. California's rigorous regulatory environment demands thorough compliance documentation.
Certificate of Analysis β Every lot should include a third-party CoA confirming identity, potency, sterility, and endotoxin levels. MedClinic Partners provides full CoA documentation through the portal for every order.
California Non-Resident Pharmacy License Verification β MedClinic Partners provides verification of our supply partners' California non-resident pharmacy licensure through the portal.
NAD+ Protocols California Clinics Are Running
GLP-1 + NAD+ Combination β California clinics are pairing NAD+ with compounded semaglutide or tirzepatide to support mitochondrial function and energy metabolism, particularly beneficial for patients experiencing fatigue during GLP-1 titration.
Longevity Medicine β LA and Bay Area longevity clinics offer NAD+ as part of comprehensive programs combining GLP-1s, peptides, hormone optimization, and advanced diagnostics.
Cognitive Performance β Silicon Valley executive health practices offer NAD+ for cognitive clarity, focus, and mental performance.
Athletic Performance and Recovery β San Diego sports medicine and active lifestyle practices use NAD+ for performance optimization and recovery.
How MedClinic Partners Serves California NAD+ Clinics
We supply USA cGMP NAD+ subcutaneous injections to licensed medical practices throughout California β Los Angeles, San Francisco, San Diego, Sacramento, Orange County, the Bay Area, and throughout rural California.
Same-Day Portal Access β California providers can apply and receive portal access within 24 hours of NPI verification. NAD+ is available through the same portal as our GLP-1 and peptide products.
Overnight Cold-Chain Delivery β All orders ship overnight in validated temperature-controlled packaging maintaining 2β8Β°C throughout transit.
California Compliance Documentation β Full CoA documentation, lot traceability, and California licensure verification are available through the portal for every order.
Getting Started as a California Provider
Apply online and receive portal access within 24 hours. Submit your NPI, California license information, and practice details. You'll have access to our full product catalog β NAD+, compounded GLP-1s, and USA cGMP RUO peptides β with transparent wholesale pricing the same day.
Explore Topics
Written by
Ian J.
Co-Founder & Managing Partner β Mass-Tort Pharma Background & Medical Operator
Ian is a co-founder of MedClinic Partners with over a decade of experience in mass-tort pharmaceutical matters and medical practice operations. He has personally overseen the launch and compliance infrastructure of multiple GLP-1 and peptide programs, and brings a unique legal-operational perspective to compounding supply chain management.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.